In October 2018, recreational use of cannabis was legalized in Canada with the primary
objectives of improving cannabis-related public health and safety, reducing youth access to …

Clinical and preclinical evidence has demonstrated an increased risk for neuropsychiatric
disorders following prenatal cannabinoid exposure. However, given the phytochemical …

Background and aims Public health concerns regarding pregnant women's health after the
enactment of the Cannabis Act in Canada (CAC)(a law that allowed non‐medical cannabis …

Background Marijuana potency and utilization both continue to increase across the United
States. While the overall prevalence of cannabinoid utilization during pregnancy has been …

Introduction Following the legalisation of non‐medical cannabis in 2018, the number of
cannabis stores in Canada has rapidly expanded with limited regulation on their geographic …

Objective Conflicting results have arisen regarding the association between prenatal
cannabis exposure and risk of parent-reported developmental delay in infancy. In certain …

In Canada, cannabis was legalized for medical purposes in 2001 and for nonmedical use in
2018, with edibles, concentrates, and topicals following in 2019 under the Canadian …

Importance: A growing number of jurisdictions have legalized recreational cannabis for
adults, but most evaluations have used repeated cross-sectional designs, preventing …

Objectives The objective of this study was to gather Ontario clinicians' and public members'
views on the design of a pre-conception patient education program. Methods In this mixed …

• En octobre 2018, l'usage du cannabis à des fins récréatives a été légalisé au Canada avec
pour principaux objectifs d'améliorer la santé publique et la sécurité, de restreindre l'accès …